Coca-Cola Europacific Partners Reports Solid Q3 Growth Driven by Innovation and Brand Activations

Reuters11-05
Coca-Cola Europacific Partners Reports Solid Q3 Growth Driven by Innovation and Brand Activations

Coca-Cola Europacific Partners plc held an analyst call to discuss their Q3 2025 trading update, featuring prepared remarks from CEO Damian Gammell, CFO Ed Walker, and VP of Investor Relations & Corporate Strategy Sarah Willett. The management highlighted major investments, including the opening of their largest canning line in Queensland, the construction of a third aseptic line in Dunkerque, and the groundbreaking of a new plant in Tarlac, Philippines. They also introduced new AI-powered "Coke & Go" smart coolers in New Zealand. A full transcript of the call will be made available on their website at https://www.cocacolaep.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coca-Cola Europacific Partners plc published the original content used to generate this news brief on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment